Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Ophthalmology
    • Artificial...

    Artificial Intelligence Shows Potential to Fight Blindness

    Written by supriya kashyap kashyap Published On 2017-04-28T15:28:06+05:30  |  Updated On 28 April 2017 3:28 PM IST
    Artificial Intelligence Shows Potential to Fight Blindness

    Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of diabetes that affects the eyes. This advance has the potential to reduce the worldwide rate of vision loss due to diabetes.




    In a study published online in Ophthalmology, the journal of the American Academy of Ophthalmology, the researchers describe how they used deep-learning methods to create an automated algorithm to detect diabetic retinopathy. Diabetic retinopathy (DR) is a condition that damages the blood vessels at the back of the eye, potentially causing blindness.


    "What we showed is that an artificial intelligence-based grading algorithm can be used to identify, with high reliability, which patients should be referred to an ophthalmologist for further evaluation and treatment," said Theodore Leng, M.D., lead author. "If properly implemented on a worldwide basis, this algorithm has the potential to reduce the workload on doctors and increase the efficiency of limited healthcare resources. We hope that this technology will have the greatest impact in parts of the world where ophthalmologists are in short supply."


    Another advantage is that the algorithm does not require any specialized, inaccessible, or costly computer equipment to grade images. It can be run on a common personal computer or smartphone with average processors.


    Deep learning is on the rise in computer science and medicine because it can teach computers to do what our brains do naturally. What Dr. Leng and his colleagues did was to create an algorithm based on more than 75,000 images from a wide range of patients representing several ethnicities, and then used it to teach a computer to identify between healthy patients and those with any stage of disease, from mild to severe.


    Dr. Leng's algorithm could identify all disease stages, from mild to severe, with an accuracy rate of 94 percent. It would be these patients that should see an ophthalmologist for further examination. An ophthalmologist is a physician who specializes in the medical and surgical treatment of eye diseases and conditions.


    Diabetes affects more than 415 million people worldwide or 1 in every 11 adults. About 45 percent of diabetic patients are likely to have diabetic retinopathy at some point in their life; however, fewer than half of patients are aware of their condition. Early detection and treatment are integral to combating this worldwide epidemic of preventable vision loss.


    Ophthalmologists typically diagnose the presence and severity of diabetic retinopathy by direct examination of the back of the eye and by evaluation of color photographs of the fundus, the interior lining of the eye. Given the large number of diabetes patients globally, this process is expensive and time-consuming. Also, previous studies have shown that detection is somewhat subjective, even among trained specialists. This is why an effective, automated algorithm could potentially reduce the rate of worldwide blindness.


    You can read the full Article by clicking on the link :


    Rishab Gargeya, Theodore Leng. Automated Identification of Diabetic Retinopathy Using Deep Learning. Ophthalmology, 2017; DOI: 10.1016/j.ophtha.2017.02.008



    blindnessByers Eye Institutediabetesdiabetic retinopathyeye diseaseTheodore Leng

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok